Longboard Pharmaceuticals is a biotechnology business based in the US. Longboard Pharmaceuticals shares (LBPH) are listed on the NASDAQ and all prices are listed in US Dollars. Longboard Pharmaceuticals employs 21 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Longboard Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – LBPH. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Longboard Pharmaceuticals stock price (NASDAQ: LBPH)
Use our graph to track the performance of LBPH stocks over time.Longboard Pharmaceuticals shares at a glance
Latest market close | $5.19 |
---|---|
52-week range | $2.70 - $6.47 |
50-day moving average | $4.68 |
200-day moving average | $4.17 |
Wall St. target price | $17.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.87 |
Buy Longboard Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Longboard Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Longboard Pharmaceuticals price performance over time
Historical closes compared with the close of $5.19 from 2023-01-27
1 week (2023-01-23) | -2.08% |
---|---|
1 month (2022-12-30) | 59.20% |
3 months (2022-10-28) | 64.76% |
6 months (2022-07-29) | 54.46% |
1 year (2022-01-28) | 24.16% |
---|---|
2 years (2021-01-26) | N/A |
3 years (2020-01-26) | N/A |
5 years (2018-01-26) | N/A |
Longboard Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -26.62% |
Return on equity TTM | -45.05% |
Profit margin | 0% |
Book value | $4.19 |
Market capitalisation | $90 million |
TTM: trailing 12 months
Longboard Pharmaceuticals share dividends
We're not expecting Longboard Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- GlaxoSmithKline PLC ADR (GSK.US) (5.36% forward annual dividend yield)
- Pfizer (PFE.US) (3.65% forward annual dividend yield)
Longboard Pharmaceuticals overview
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.
Longboard Pharmaceuticals in the news
Hedge funds investors have a lot riding on Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) with 27% ownership
Frequently asked questions
What percentage of Longboard Pharmaceuticals is owned by insiders or institutions?Currently 25.134% of Longboard Pharmaceuticals shares are held by insiders and 44.012% by institutions. How many people work for Longboard Pharmaceuticals?
Latest data suggests 21 work at Longboard Pharmaceuticals. When does the fiscal year end for Longboard Pharmaceuticals?
Longboard Pharmaceuticals's fiscal year ends in December. Where is Longboard Pharmaceuticals based?
Longboard Pharmaceuticals's address is: 4275 Executive Square, La Jolla, CA, United States, 92037 What is Longboard Pharmaceuticals's ISIN number?
Longboard Pharmaceuticals's international securities identification number is: US54300N1037
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert